article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

In the future, the most effective and ethical research won’t rely on tradition – it will be driven by technology, transparency and trust. Federal ruling on USDA primate welfare petition, 2023. National Research Council. FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs.

article thumbnail

Drug-Linked Disciplinary Actions by Schools Spiked After Oregon Legalized Marijuana

Drugs.com

23, 2023 -- New research suggests a link between middle school students being disciplined for marijuana use and legalization of recreational weed, particularly when schools are close to dispensaries that sell the drug. Researchers. MONDAY, Oct.

Drugs 276
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HIGH SCHOOL SCIENTISTS AND ENGINEERS WIN NEARLY $9 MILLION AT THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR 2023

The Pharma Data

HIGH SCHOOL SCIENTISTS AND ENGINEERS WIN NEARLY $9 MILLION AT THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR 2023 Regeneron Pharmaceuticals, Inc. Congratulations to the Regeneron International Science and Engineering Fair 2023 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.

article thumbnail

Drug Channel Implications of the Inflation Reduction Act (NEW Live Video Webinar)

Drug Channels

The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. This event is part of The Drug Channels 2024 Video Webinar Series. The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. billion in 2023 and is expected to grow at a CAGR of 7.0% billion in 2023 and is expected to grow at a CAGR of 7.0% over this period.

article thumbnail

Article FDA Thank You FDA’s new guidance explains what to do during a BIMO inspection

Agency IQ

According to the fiscal year 2023 metrics (the most recent available), the BIMO program conducted over 1,000 inspections in FY 2023, with most (779) for CDER-regulated products. Notably, 2023 saw a near-return to regular order after the pandemic. Notably, 2023 saw a near-return to regular order after the pandemic.

FDA 40
article thumbnail

Article EMA Thank You With all nitrosamines deadlines passed, EMA updates its guidelines

Agency IQ

BY KIRSTEN MESSMER, PHD, RAC | NOV 17, 2023 4:46 PM CST Quick background on nitrosamines in global medicinal products Nitrosamines are a large and diverse class of chemicals, with more than 300 different structurally distinct species known today. In a study of more than 12,000 small molecule drugs , researchers found 40.4%